Therapeutic Group: Gastro Intestinal Disorders » Laxative
Presentation

Inolac oral solution: Each 5 ml oral solution contains Lactulose USP 3.35 gm.
Descriptions

Indications

Treatment of acute and the prevention and treatment of chronic Portal-systemic encephalopathy including
the stages of hepatic pre-coma and coma.
Dosage & Administration

Adults: Initially 15 ml twice daily, adjusted according to patient's need.
Children: Under 1 year: 2.5 ml twice daily
1-5 years: 5 ml twice daily
5-10 years: 10 ml twice daily
Hepatic encephalopathy: 30-50 ml 3 times daily, subsequently adjusted to produce 2-3 soft stools daily.
Side Effects

Precautions

Contraindications

Use in Pregnancy & Lactation

Pregnancy Category B. Lactulose oral solution has been shown to be safe and effective for the treatment of constipation associated with pregnancy when administered to women at different stages of pregnancy.
Lactation
It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when lactulose is administered to a nursing woman.
Overdose

Commercial Packaging

Gastro Intestinal Disorders
Anti Hemorrhoid
Antiulcerant
PPI
Antacid
Magaldrate tablet
Magaldrate BP and Simethicone USP
Sodium Alginate & Potassium Bicarbonate Tablet & Suspension
H2 Blocker
Ranitidine Hydrochloride BP
Anti Flatulent
Simethicone Drops
Irritable Bowel Syndrome
Laxative
Prokinetic-Antiemetic
Domperidone tablet/dispersible tablet/suspension/paediatric drops





